Displaying 91 - 100 of 518
Each year, experts from the field of endocrinology convene at the AACE Annual Meeting to learn about the latest advancements in clinical endocrinology. Our 2021 Annual Meeting took place on May 26-29, and was a successful virtual event with thousands of attendees. Not only did we celebrate 30 years of clinical excellences at AACE, but we also welcomed attendees from over 140 countries. Our program featured 150+ expert presenters covering six disease state topics tracts with 130+ sessions, and 86+ CME, nursing and pharmacy credits. As…
moreTo our AACE Community,
Without a doubt, I know the last two years have not been easy for any of us. These uncertain times with a global pandemic have led to challenges across our personal and professional lives, and at AACE our strategic priorities have faced required nimbleness as well. Wherever you are on your journey, my thoughts have been and continue to be with you.
Still, we at AACE are committed to our vision of achieving healthier communities through endocrine innovation, education, and care — and one of the ways we do this is through vital meetings and connectivity. After…
moreArchived: This blog is from our 2021 Bone and Parathyroid Disease State Network
The Bone and Parathyroid Disease State Network (DSN) is composed of a group of clinicians who have expertise in disorders of bone and mineral metabolism. We encourage participation from any provider who has interest in such disorders. We can always use your help, and participation in our DSN can certainly enhance your career, give you a voice in several venues within AACE, and provide exposure at national and International levels within AACE. This is also a great way to get to know AACE…
more
Archived: This blog is from our 2021 Pituitary, Gonadal, Adrenal, and Neuroendocrine (PGAN) Disease State Network
The pituitary, gonadal, adrenal, and neuroendocrine (PGAN) disease state network (DSN) is one of the most topically inclusive DSNs. To expand this inclusivity to our members, we at the DSN are here to represent and work for the AACE community. Together we will be proposing, developing, and disseminating topics of interest to PGAN, but we really need your involvement. With your help, we hope to address knowledge deficits and highlight areas in need of action. Your voice…
more
Archived: This blog is from our 2021 Diabetes Disease State Network
We are a community of endocrinology and diabetes specialists passionate about diabetes clinical care, education, and advocacy. My interest in diabetes began serendipitously in medical school at the University of Rochester, New York. I had decided to take a year out of school and needed a research project. I was hired by Dr. Barry Gumbiner, an Endocrinology faculty member who turned out to be a wonderful mentor. He needed a student for a General Clinical Research Center project comparing weight loss, weight loss…
more
AACE Asia-Pacific (APAC)
As a forward-thinking organization, we are committed to expanding our global presence through our strategic goals, which includes fostering worldwide engagement within the broader endocrine community to improve global health. To support this initiative, we offer educational opportunities and events at key destinations across the globe, enabling participants to connect with AACE experts, stay informed about the latest advancements in clinical endocrinology, and network with peers in their regions.
Explore our international events and opportunities below:
moreWith our
recent announcement about the new AACE Communities initiative that will offer regional events at a global scale, we are happy to share that MCI is teaming up with AACE as a regional office to bring educational opportunities and more to areas within Latin America and Asia-Pacific.
AACE Communities feature premier educational offerings and expert speakers for our clinical endocrinology community in regions around the world, that supports AACE’s mission and brand. Initial work is underway on…
moreArchived: This blog is from our 2021 Cardiometabolic and Lipids Disease State Network
I am honored to serve as the Cardiometabolic and Lipids Disease State Network (DSN) chair this year. I am a professor of medicine at Case Western Reserve Medical School, Vice-Chair of Internal Medicine, and Director for Diabetes and Obesity Center at the University Hospitals. I started my career in Chicago with a clinical research interest in islet cell transplants; I also built a clinical diabetes wellness program for the University of Illinois in Chicago. After moving to the Cleveland Clinic…
more
Several clinical trials have studied the effects of blocking FGF-23, a phosphatonin, in the treatment of X-linked hypophosphatemia (XLH), a genetic disorder associated with inactivating mutations in the Phosphate Regulating Endopeptidase Homolog X-Linked (PHEX) gene resulting in an upregulation of FGF-23 expression and subsequent hypophosphatemia. These studies demonstrated efficacy with minimal safety concerns in both pediatric and adult cohorts, leading to the approval of burosumab (formerly known as KRN23), a human anti-FGF23 monoclonal antibody, by the US Food and Drug Administration (FDA…
moreNow Live - AACE Community Engagement
Interested in engaging with your peers about the latest endocrine news and advancements? Now you can connect with our global community of health care professionals by visiting our disease state discussions. Written by our team of disease state network health care professionals, our medical experts will post discussion topics and articles for you to comment on, ask questions, and share your knowledge. Topics will cover the broad spectrum of patient care, novel treatment recommendations, clinical practice guidelines, latest news, and much more.…
more
